Suppr超能文献

儿童肾移植受者中促红细胞生成素、铁相关和 FGF23 参数之间的关系。

Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients.

机构信息

Department of Pediatrics, Division of Pediatric Nephrology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, MDCC A2-383, Los Angeles, CA, 90095-1752, USA.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095-1752, USA.

出版信息

Pediatr Nephrol. 2021 Oct;36(10):3241-3249. doi: 10.1007/s00467-021-05081-0. Epub 2021 Apr 26.

Abstract

BACKGROUND

In pediatric kidney transplant recipients, anemia is common and oftentimes multifactorial. Hemoglobin concentrations may be affected by traditional factors, such as kidney function and iron status, as well as novel parameters, such as fibroblast growth factor 23 (FGF23).

METHODS

Here, we evaluated associations among erythropoietic, iron-related, and FGF23 parameters in a cohort of pediatric kidney transplant recipients, hypothesizing that multiple factors are associated with hemoglobin concentrations.

RESULTS

In a cross-sectional analysis of 59 pediatric kidney transplant recipients (median (interquartile range) age 16.3 (13.5, 18.6) years, median estimated glomerular filtration rate (eGFR) 67 (54, 87) ml/min/1.73 m), the median age-related hemoglobin standard deviation score (SDS) was -2.1 (-3.3, -1.1). Hemoglobin SDS was positively associated with eGFR and calcium, and was inversely associated with erythropoietin (EPO), mycophenolate dose, and total, but not intact, FGF23. In multivariable analysis, total FGF23 remained inversely associated with hemoglobin SDS, independent of eGFR, iron parameters, EPO, and inflammatory markers, suggesting a novel FGF23-hemoglobin association in pediatric kidney transplant patients. In a subset of patients with repeat measurements, only delta hepcidin was inversely associated with delta hemoglobin SDS. Also, delta EPO positively correlated with delta erythroferrone (ERFE), and delta ERFE inversely correlated with delta hepcidin, suggesting a possible physiologic role for the EPO-ERFE-hepcidin axis in the setting of chronic kidney disease (CKD).

CONCLUSION

Our study provides further insight into factors potentially associated with erythropoiesis in pediatric kidney transplant recipients. A higher resolution version of the Graphical abstract is available as Supplementary information.

摘要

背景

在儿科肾移植受者中,贫血很常见,且往往是多因素的。血红蛋白浓度可能受到传统因素(如肾功能和铁状态)以及新型参数(如成纤维细胞生长因子 23(FGF23))的影响。

方法

在这里,我们评估了儿科肾移植受者队列中促红细胞生成、铁相关和 FGF23 参数之间的关联,假设多种因素与血红蛋白浓度有关。

结果

在对 59 名儿科肾移植受者的横断面分析中(中位数(四分位距)年龄 16.3(13.5,18.6)岁,中位数估算肾小球滤过率(eGFR)67(54,87)ml/min/1.73 m2),年龄相关血红蛋白标准差评分(SDS)的中位数为-2.1(-3.3,-1.1)。血红蛋白 SDS 与 eGFR 和钙呈正相关,与促红细胞生成素(EPO)、霉酚酸剂量和总但不完整的 FGF23 呈负相关。在多变量分析中,总 FGF23 与血红蛋白 SDS 呈负相关,与 eGFR、铁参数、EPO 和炎症标志物独立相关,提示在儿科肾移植患者中存在新型 FGF23-血红蛋白关联。在具有重复测量的患者亚组中,只有 delta 铁调素与 delta 血红蛋白 SDS 呈负相关。此外,delta EPO 与 delta 红细胞生成素受体激动剂(ERFE)呈正相关,而 delta ERFE 与 delta 铁调素呈负相关,提示 EPO-ERFE-铁调素轴在慢性肾脏病(CKD)中可能具有生理作用。

结论

我们的研究进一步深入了解了与儿科肾移植受者红细胞生成相关的潜在因素。更清晰的图表摘要版本可作为补充信息获取。

相似文献

1
Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients.
Pediatr Nephrol. 2021 Oct;36(10):3241-3249. doi: 10.1007/s00467-021-05081-0. Epub 2021 Apr 26.
2
Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
Kidney Int. 2021 Jul;100(1):79-89. doi: 10.1016/j.kint.2021.03.019. Epub 2021 Mar 31.
4
Associations between anemia and FGF23 in the CKiD study.
Pediatr Nephrol. 2024 Mar;39(3):837-847. doi: 10.1007/s00467-023-06160-0. Epub 2023 Sep 26.

引用本文的文献

1
Associations between anemia and FGF23 in the CKiD study.
Pediatr Nephrol. 2024 Mar;39(3):837-847. doi: 10.1007/s00467-023-06160-0. Epub 2023 Sep 26.
2
Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease.
Pediatr Nephrol. 2023 Aug;38(8):2771-2779. doi: 10.1007/s00467-023-05903-3. Epub 2023 Mar 2.
3
Anemia in Pediatric Kidney Transplant Recipients-Etiologies and Management.
Front Pediatr. 2022 Jun 20;10:929504. doi: 10.3389/fped.2022.929504. eCollection 2022.

本文引用的文献

1
Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e288-e299. doi: 10.1210/clinem/dgaa716.
3
The REDCap consortium: Building an international community of software platform partners.
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
4
Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
Nephrology (Carlton). 2019 Aug;24(8):819-826. doi: 10.1111/nep.13495. Epub 2019 Apr 29.
5
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.
Nephrol Dial Transplant. 2019 Dec 1;34(12):2057-2065. doi: 10.1093/ndt/gfy189.
6
Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
Pflugers Arch. 2018 Oct;470(10):1569-1582. doi: 10.1007/s00424-018-2171-7. Epub 2018 Jul 2.
8
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
FASEB J. 2018 Jul;32(7):3752-3764. doi: 10.1096/fj.201700667R. Epub 2018 Feb 26.
9
Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease.
Haematologica. 2018 Apr;103(4):e141-e142. doi: 10.3324/haematol.2017.181743. Epub 2018 Feb 1.
10
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.
Kidney Int. 2018 May;93(5):1131-1141. doi: 10.1016/j.kint.2017.11.018. Epub 2018 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验